Early monitoring of response to antimetabolic treatment of gemcitabine: A comparison of 18F-FLT and 18F-FDG uptake in Patu 8988 human pancreatic carcinoma cells
Early monitoring of response to antimetabolic treatment of gemcitabine: A comparison of 18F-FLT and 18F-FDG uptake in Patu 8988 human pancreatic carcinoma cells